Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic acid + Collagen is a combination biomaterial medical device being developed by Abiogen for the treatment of pain, specifically within the context of osteoarticular and bone health. This product is designed as a viscosupplement and tissue-support biomaterial. Hyaluronic acid serves to restore the lubricating and shock-absorbing properties of synovial fluid in joints, while the addition of collagen provides a structural scaffold that may support tissue repair and integrity. The combination is primarily intended for intra-articular use to alleviate pain and improve mobility in patients with degenerative joint conditions such as osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hyaluronic acid + collagen.